Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Venture Life ( (GB:VLG) ).
Venture Life Group has repurchased 88,684 ordinary shares at a volume‑weighted average price of 67.93 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 5,902,281 are held in treasury, leaving 122,957,864 voting rights outstanding for shareholders to use as the basis for regulatory disclosure calculations.
The buyback slightly reduces the free float and may support earnings per share and capital allocation objectives, signalling continued management commitment to share repurchases. The updated voting rights figure provides clarity for investors and regulators on ownership thresholds and disclosure requirements under the FCA’s transparency rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is a UK‑headquartered international consumer self‑care company operating in the global consumer healthcare sector. Its portfolio includes products such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and Health & Her for hormonal lifecycle support, sold via pharmacies, health and beauty retailers, grocery chains, and e‑commerce, both directly and through international distributors.
Average Trading Volume: 333,709
Technical Sentiment Signal: Buy
Current Market Cap: £83.06M
For a thorough assessment of VLG stock, go to TipRanks’ Stock Analysis page.